Adverse cutaneous reactions to influenza vaccinations and chemotherapy.
Holdiness
M R
MR
Department of Internal Medicine, Lakeside Hospital, Metairie, Louisiana 70001, USA. MHoldi1540@compuserve.com
D000081:Acetamides / Q000627:therapeutic use; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D064420:Drug-Related Side Effects and Adverse Reactions; D006146:Guanidines; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects* / Q000627:therapeutic use; D007251:Influenza, Human / Q000517:prevention & control / Q000821:virology; D009975:Orthomyxoviridae / Q000187:drug effects; D053139:Oseltamivir; D011714:Pyrans; D012299:Rimantadine / Q000627:therapeutic use; D012794:Sialic Acids / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D006146:Guanidines; D007252:Influenza Vaccines; D011714:Pyrans; D012794:Sialic Acids; D012299:Rimantadine; D053139:Oseltamivir; D000547:Amantadine; D053243:Zanamivir